Your browser doesn't support javascript.
loading
Comment on: Failure of rivaroxaban to prevent thrombosis in four patients with anti-phospholipid syndrome.
Scanvion, Quentin; Morell-Dubois, Sandrine; Yelnik, Cécile M; Bene, Johana; Gautier, Sophie; Lambert, Marc.
Affiliation
  • Scanvion Q; CHU Lille, Internal Medicine Department, National Reference Center for Rare Autoimmune Systemic Diseases, Lille, F-59000, France.
  • Morell-Dubois S; CHU Lille, Internal Medicine Department, National Reference Center for Rare Autoimmune Systemic Diseases, Lille, F-59000, France.
  • Yelnik CM; CHU Lille, Internal Medicine Department, National Reference Center for Rare Autoimmune Systemic Diseases, Lille, F-59000, France.
  • Bene J; CHU Lille, Pharmacology Department, Centre Régional de PharmacoVigilance, Université Lille Nord de France, Lille, F-59000, France.
  • Gautier S; CHU Lille, Pharmacology Department, Centre Régional de PharmacoVigilance, Université Lille Nord de France, Lille, F-59000, France.
  • Lambert M; CHU Lille, Internal Medicine Department, National Reference Center for Rare Autoimmune Systemic Diseases, Lille, F-59000, France.
Rheumatology (Oxford) ; 57(5): 938-939, 2018 05 01.
Article in En | MEDLINE | ID: mdl-29373704

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiphospholipid Syndrome / Rivaroxaban Limits: Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2018 Document type: Article Affiliation country: France Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiphospholipid Syndrome / Rivaroxaban Limits: Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2018 Document type: Article Affiliation country: France Country of publication: United kingdom